Evonik VESTAMID® Care ML94 is an unreinforced, plasticizer-free polyamide 12 (PA12) resin formulated for medical device components that require a controlled balance of flexibility, resistance to environmental stress cracking, and low extractable content. The grade is categorized as a medium-viscosity, high-molecular-weight PA12 under ISO 1874-1 nomenclature. It is supplied in natural spherical granules with viscosity number controlled per ISO 307 and an extractables profile characterized under ISO 10993-18. Typical target components include extruded catheter shafts, multi-lumen tubing, injection-molded hubs, connectors, and secondary devices where repeated flexural loading and compatibility with common terminal sterilization modalities are specified. The material is manufactured under ISO 13485 quality management with medical-grade change control and lot traceability.

Compared with short-chain aliphatic polyamides such as PA6 and PA66, the PA12 backbone has a longer methylene sequence between amide groups. This reduces equilibrium moisture uptake, lowers density to approximately 1.01 g/cm³ per ISO 1183-1, and limits property shift between dry-as-molded and conditioned states. The glass transition temperature is below 0 °C, while the melting peak is reported near 175–179 °C by ISO 11357-3 differential scanning calorimetry. These thermal transitions permit cold-temperature flexion without sacrificing dimensional stability at body temperature. The grade is classified for surface-contact and tissue-contact applications; implant duration limits remain dependent on final device biological evaluation under ISO 10993-1.

What specifications define VESTAMID® Care ML94 as a medical-grade nylon 12?

The tabulated values are representative of the unreinforced grade in the dry-as-molded state. Lot-specific certificates of analysis may vary within the product specification envelope, and final performance must be validated on the finished device after sterilization and conditioning.

Drying and melt-processing envelope for catheter tubing and molded components

Moisture content at the feed throat controls melt viscosity, surface quality, and hydrolytic stability. Hydrolysis in PA12 becomes measurable when residual moisture exceeds 0.10% during extended melt residence. A desiccant dryer is specified at 80 °C for 4–6 h until the resin reaches <0.10% moisture, verified by a halogen moisture analyzer or Karl Fischer titration. In production areas where ambient relative humidity exceeds 60%, drying time is extended to 8 h, and the dried resin is conveyed under dry-air purge to the hopper. If central drying and pneumatic conveying are used, the conveying air is dried to a dew point below -40 °C to prevent rehydration. Hopper residence time is matched to throughput so that dried resin is consumed within 2 h; if processing is interrupted, the resin must be redried before restart.

On production-scale single-screw extruders configured with 24:1–30:1 L/D barrier screws, the temperature profile from rear zone to die is commonly set at 200 °C, 220 °C, 230 °C, 240 °C, 240 °C, with adapter and die at 235–245 °C. A melt pump between the screw tip and die reduces pressure pulsation and stabilizes wall thickness. Melt temperature measured at the die adapter should not exceed 250 °C. Melt residence times above 10 min at 240 °C are avoided to prevent thermo-oxidative gel formation and discoloration. Grooved-barrel extruders with water-cooled feed throats improve solids conveying and allow higher throughput; with a conventional smooth-bore extruder, screw speed must be reduced by 10–20% to avoid feed-blocking and melt-pressure fluctuation. Barrier screws with a compression ratio of 2.5:1–3.5:1 and Maddock mixing elements improve melt homogeneity, while intensive mixing elements are avoided because excessive shear heating can push melt temperature above 250 °C.

Rheologically, the grade exhibits shear-thinning behavior typical of linear PA12. At a melt temperature of 240 °C, apparent melt viscosity measured by capillary rheometry at a shear rate of 100 s⁻¹ is estimated in the range of 200–400 Pa·s; at 1,000 s⁻¹, viscosity falls to approximately 80–150 Pa·s. These values are not product-certified and should be confirmed by lot-specific capillary data when designing extrusion tooling. For tube sizing, vacuum calibration in a water bath set to 20–40 °C is applied. Drawdown ratio is maintained between 1.2:1 and 3:1 to avoid frozen-in orientation that reduces hoop stress retention after sterilization.

In injection molding of hubs and connectors, a barrel profile of 220–250 °C, nozzle temperature of 240–250 °C, and mold temperature of 40–80 °C are recommended. Holding pressure is maintained at 600–1,000 bar for thin-wall components, and gate dimensions are designed to allow packing without jetting. For mold temperatures below 40 °C, rapid crystallization can reduce weld-line strength; above 80 °C, cycle time increases without a significant further increase in degree of crystallinity. After molding or extrusion, PA12 absorbs atmospheric moisture. Equilibrium moisture content at 23 °C and 50% RH is approximately 0.7%. This conditioning reduces tensile modulus and increases impact resistance. Linear dimensional change from dry to conditioned state is typically 0.2–0.4%; final device dimensions are therefore verified after conditioning rather than immediately after processing.

Observed failure modes on manufacturing lines include melt-pressure spikes and gel formation when melt temperature exceeds 260 °C. Batch-to-batch viscosity number is controlled to ±5 mL/g; moisture excursions above 0.10% cause surface splay and voids in extruded tubing. When regrind is used in non-critical layers or components, the maximum regrind addition is limited to 20% by weight with the same lot, and the regrind is redried to <0.10% moisture. For invasive or blood-contacting layers, regrind use is generally excluded unless final device validation demonstrates equivalent biocompatibility.

When gamma irradiation and ethylene oxide sterilization are applied to PA12 medical devices

Gamma irradiation at 25–50 kGy is commonly used for single-use devices. The aliphatic PA12 backbone undergoes limited chain scission; at the upper dose, tensile elongation may shift relative to unsterilized controls, so design margins for catheter kink resistance should be validated at maximum dose. Electron beam exposure at equivalent doses is acceptable if dose mapping confirms uniform absorption through the packaged device. Sterilized device performance is governed by dose, moisture conditioning, and wall thickness; published data for device-specific post-sterilization mechanical change is limited, and final dose mapping plus post-sterilization testing is required.

Ethylene oxide sterilization is performed at 45–60 °C and relative humidity 40–80%. Because PA12 absorbs moisture and ethylene oxide, the material must be aerated according to ISO 10993-7 to reduce residual ethylene oxide and ethylene chlorohydrin below device-specific limits. EtO sterilized devices may gain approximately 0.7% moisture at 50% RH equilibrium; this conditioned state lowers tensile modulus compared with dry-as-molded data and must be accounted for in functional testing.

Regulatory, biological, and chemical characterization compliance matrix

The biological data above are generated on standardized plaques or tubes. They do not replace final device biological evaluation under ISO 10993-1:2018 Clause 4.1, which requires documented justification for every tested endpoint. Material suppliers typically maintain a drug master file or master access letter to support regulatory submissions, but the final device manufacturer remains responsible for lot release, extractables, and stability data. The material is supplied free of animal-derived components; supplier documentation includes TSE/BSE statements and compliance with EU 2017/745 Annex I General Safety and Performance Requirements.

VESTAMID Care grade selection and property trade-offs

Within the VESTAMID Care family, ML94 is positioned as a higher-molecular-weight, higher-melt-strength PA12 for thin-wall tubing and components that require resistance to environmental stress cracking when tested by ISO 22088-3. Compared with lower-viscosity grades in the same series that are optimized for high-speed extrusion of simple thin-wall shaft, ML94 may require lower melt output per screw revolution and generate higher die pressure. This trade-off is acceptable when hoop stress retention, burst pressure, and repeated flexural endurance at catheter shaft articulation points are the primary acceptance criteria.

Compared with glass-fiber-reinforced PA12 compounds, ML94 exhibits lower tensile modulus and higher elongation to break. Glass-filled grades typically reach flexural modulus values above 4,000 MPa, while ML94 remains near 1,400 MPa; therefore ML94 is not selected for rigid load-bearing hubs. Conversely, glass-filled grades fail by brittle fracture at low elongation and are not suitable for flexible catheter shafts or living hinges.

Compared with plasticized flexible PA12 or PVC, ML94 achieves flexibility through the PA12 backbone and molecular weight distribution rather than external plasticizer. This avoids surface tack, plasticizer migration, and extractable phthalate concerns, and maintains mechanical properties after gamma and EtO sterilization. The absence of plasticizer does, however, impose a higher Shore D hardness and bending modulus than ultra-soft plasticized systems; devices requiring Shore A hardness below 80 cannot be realized with ML94 alone.

In multi-lumen catheter shaft manufacturing, the resin is dried to <0.10% moisture, extruded at 220–240 °C, and drawn through a vacuum calibration tank at 20 °C. Wall thickness is monitored by ultrasonic gauge with a capability index Cpk greater than 1.33. After EtO sterilization and aeration, kink resistance and burst pressure are verified on finished devices according to ISO 10555-1 and ISO 10555-3 as applicable. Published data for device-specific kink radius and cycle fatigue is limited; each design requires benchtop testing at body temperature and after maximum sterilization dose.